Search - tctmd.com

Displaying 201 - 220 of 376

Sort: Relevancy | Date

News Industry News

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

December 01, 2015

News Daily News

Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences

Todd Neale

November 22, 2015

News Daily News

Los Episodios Neurológicos Post-PCI aunque Poco Frecuentes siguen Acarreando Consecuencias ‘Abismales’

Todd Neale

November 22, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Conference News VEITH 2015

Experts Continue to Grapple With Stenting or Endarterectomy for Carotid Stenosis

Todd Neale

November 18, 2015

News Industry News

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

November 02, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Presenter: William A. Gray, D. Christopher Metzger, Herbert D. Aronow

October 14, 2015

Presentation TCT 2015

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek

October 14, 2015

Presentation TCT 2015

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Presenter: William A. Gray, D. Christopher Metzger, Piotr Musialek

October 14, 2015

Presentation TCT 2015

Update on the ACST-2 Trial: Early Outcomes and Perspectives on the Field From Across the Pond

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Presenter: William A. Gray, D. Christopher Metzger

October 14, 2015

Presentation TCT 2015

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

Presenter: William A. Gray, D. Christopher Metzger, Gary S. Roubin

October 14, 2015

Presentation TCT 2015

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Presenter: William A. Gray, D. Christopher Metzger, Klaus D. Mathias

October 14, 2015

Presentation TCT 2015

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in the Patient With Carotid Disease

Presenter: William A. Gray, D. Christopher Metzger, Jan Sloves

October 14, 2015

Presentation TCT 2015

TCT 74: Proximal Balloon Occlusion Versus Distal Filter Protection in Carotid Artery Stenting A Meta-analysis of Clinical Trial Data

Presenter: Mark C. Bates, Mark H. Wholey, Jad Omran

October 13, 2015

Presentation TCT 2015

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

Presenter: Mark C. Bates, Mark H. Wholey, Piotr Musialek

October 13, 2015

Presentation TCT 2015

TCT 71: Safety and Efficacy of Carotid Stenting With Proximal Embolic Protection Through Transradial/Brachial Approach Results in 60 Consecutive Patients

Presenter: Mark C. Bates, Mark H. Wholey, Piero Montorsi

October 13, 2015

Presentation TCT 2015

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Presenter: Mark C. Bates, Mark H. Wholey, Fabio Lima

October 13, 2015

Advertisement

InspireMD Receives EU Regulatory Approval for Additional Supplier of CGuard™ Delivery Catheters

Post-PCI Neurological Events, Though Infrequent, Continue to Carry ‘Abysmal’ Consequences

Los Episodios Neurológicos Post-PCI aunque Poco Frecuentes siguen Acarreando Consecuencias ‘Abismales’

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Experts Continue to Grapple With Stenting or Endarterectomy for Carotid Stenosis

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Nonsense, Patient Safety Above All Else!

Debate: Should Carotid Stenting Volume Requirements Be Markedly Decreased or Eliminated? Yes, Given the Drop in Activity Resulting From a Lack of Reimbursement and No Data Showing They Are Necessary!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Mesh-Covered Stents for Carotid Intervention: Rationale, Device Designs, Imaging, and Data to Date

Update on the ACST-2 Trial: Early Outcomes and Perspectives on the Field From Across the Pond

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? Another Failed NIH-Funded Study: CREST-2 Is CORAL Redux (or Worse)!

Debate: Is CREST-2 a Worthwhile Use of Precious Resources? The CREST-2 Trial Is the Right Trial at the Right Time!

What Are the Hard Data Regarding the Impact of Medical Therapy on Stroke Prevention in Established Severe Carotid Stenosis?

Beyond Stenosis Severity: Top 5 Important Duplex Characteristics to Identify in the Patient With Carotid Disease

TCT 74: Proximal Balloon Occlusion Versus Distal Filter Protection in Carotid Artery Stenting A Meta-analysis of Clinical Trial Data

TCT 73: Impact of Routine MicroNet-Covered Embolic Prevention Stent System Use on Contemporary Carotid Revascularization All-Comer PARADIGM Study

TCT 71: Safety and Efficacy of Carotid Stenting With Proximal Embolic Protection Through Transradial/Brachial Approach Results in 60 Consecutive Patients

TCT 69: Impact of Stage 5 Chronic Kidney Disease in Patients Undergoing Percutaneous or Surgical Carotid Artery Revascularization Insights of the Healthcare Cost and Utilization Project's National Inpatient Sample

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content